Stony Brook-developed cancer drug advances to human clinical trials

by rss feed | Nov 6, 2026 | News Feeds

A promising new cancer chemotherapeutic agent from a taxane class of natural compounds – anti-cancer agents designed to block cell division and trigger the programmed cell death to treat sold tumors – originally developed by researchers at Stony Brook University has...

Rising grocery prices linked to higher food anxiety and insufficiency

by rss feed | Nov 6, 2026 | News Feeds

As grocery prices continue to rise, a study by researchers at Penn State found that in addition to increased spending, the price hikes also are associated with higher risk of food insufficiency and worse mental health conditions. Read Original...

New review outlines role of extracellular vesicles in cancer and aging

by rss feed | Nov 6, 2026 | News Feeds

A new review was published in Volume 13 of Oncoscience on September 30, 2026, titled "Extracellular vesicles in health, aging and disease." Read Original...

SCAI updates consensus framework for assessing cardiogenic shock severity

by rss feed | Nov 6, 2026 | News Feeds

The Society for Cardiovascular Angiography & Interventions (SCAI) today released the 2026 SCAI SHOCK Classification Expert Consensus Update, providing refined guidance to help clinicians from diverse settings prioritize and recognize inadequate organ perfusion across...

Study uncovers new shortcut mechanism behind cancer cell division

by rss feed | Nov 6, 2026 | News Feeds

Living cells are one of the few materials that can replicate themselves, and this is crucial for tissue development and recovering from injury or illness. Read Original...